A thoughtful patient engagement strategy unlocks benefits that may surprise you, like operational efficiency and new revenue streams. Learn the ins and outs of how patient engagement makes it possible.
Hospital pharmacy security is no joke, and we take it as seriously as you do. We speak hospital security reviews, so you can run your pharmacy with peace of mind.
Ann will lead the company’s efforts to develop products that support pharmacists and pharmacies in their evolving role as healthcare providers. DALLAS, TX – April 4, 2022: OmniSYS, a leading
Pharmacy Times recap of the current status of the test to treat initiative, featuring OmniSYS CIO David Pope, PharmD, CDE. Despite AMA pushback, pharmacy is ready for test and treat.
The Drug Topics editorial board, including OmniSYS CIO David Pope, PharmD, CDE responds to the AMA’s recent negative statement regarding the test to treat initiative outlined by the Biden Administration.
Since the SOTU address, test and treat has been everywhere. But what does it mean, and what are the next steps? Stay on top of this breaking news story here.
Pharmacy Times interview with OmniSYS CIO David Pope and Christina Madison, The Public Health Pharmacist, discussing the new test to treat plan mentioned in the 2022 State of the Union.
Test to treat in pharmacy: Drug Topics asked OmniSYS chief innovation officer David Pope for his thoughts regarding test to treat after President Biden’s 2022 State of the Union address.
Clinical pharmacy is in demand and sustainable pharmacy technology makes it happen. Pharmacies must make the most of current technology investments, and building upon them for an automated, efficient future.